Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SAYSD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMURF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSNK1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YPEL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4755 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ISCU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ROPN1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM27B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGC45922 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAKD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF827 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUMF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on